Koch Kevin

President and CEO, DirectorEdgewise Therapeutics, Inc. (EWTX) · full profile →Form 4 · filed Aug 14, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$107K
Net Open-Market Flow
-$107K
Transactions
5
2 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 12, 2025Sell(S)8K$13.39$107K31K
Aug 12, 2025Option exercise(M)18K$039K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 12, 2025Grant(A)525K$0525K
Aug 12, 2025Grant(A)88K$088K
Aug 12, 2025Option exercise(M)18K$054K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-005795) within minutes of acceptance. Every field above traces to the original document. Verify it directly: